Since the early 1990s, when Roberts and Szabos cytoprotection concept had already been more than one decade old, but still not implemented in therapy, we suggest the stable gastric pentadecapeptide BPC 157 as the most relevant mediator of the cytoprotection concept.
Oral doses tend to be higher - 500 mcg to 1000 mcg twice daily - because oral bioavailability is presumably lower than injectable, though we don't have good human pharmacokinetic data
Heightened inflammation: Dysregulated NF-kB pathways promote pro-inflammatory cytokines
Lintner, K., Gerstein, F., & Solish, N
Melanocortin-derived tripeptide KPV has anti-inflammatory potential
Here are several examples of what this research has shown: Heart disease Vitamin B12 supplements (along with folic acid and vitamin B6) do not reduce the risk of getting heart disease